BIXLENVO FDA approval date
The FDA approved BIXLENVO on 27 Aug 2026.
- FDA approval date
- 27 Aug 2026
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as BICTEGRAVIR SODIUM; LENACAPAVIR SODIUM
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2026-08-27Day | BIXLENVO | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA221104", "applicant_as_listed_by_fda": "GILEAD SCIENCES INC", "brand_names": ["BIXLENVO"], "active_ingredients": ["BICTEGRAVIR SODIUM", "LENACAPAVIR SODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260827", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |